Navigation Links
Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent
Date:2/28/2008

The new hybrid operating and electrophysiology rooms alone will increase the Heart Hospital of Austin's capacity by more than 1,000 patients annually.

The hospital serves as a primary site for the nationally recognized research efforts of Austin Heart, the cardiology group based at the hospital. As one of the largest private practice clinical research programs in the nation, various types of research are conducted involving new drugs, devices, and new indications for existing therapies. The expansion of the facility and technology further the mission of the research.

To highlight some of the new technologies, two procedures were broadcast today via the new video equipment permanently installed in the rooms. Dr. Roger Gammon, cardiologist with Austin Heart, performed a live vascular procedure and Dr. Stephen Settle, vascular surgeon with Cardiothoracic and Vascular Surgeons, walked participants through a taped endovascular (minimally invasive) aneurysm repair for an Abdominal Aortic Aneurysm (AAA).

Heart Hospital of Austin

Fact Sheet

Austin's First Hybrid Operating Room

-- Austin's only combination Hybrid Operating Room and Cardiac

Catheterization Laboratory larger in size than traditional operating

rooms and incorporating catheterization laboratory-quality equipment.

-- Handles more complex and high-risk procedures such as an endovascular

aneurysm repair for an abdominal aortic aneurysm (AAA).

-- Room allows for an endovascular, less invasive procedure and can change

quickly into an operating suite during a procedure if open surgery is

required.

-- Philips FD-20 High-Resolution Cardiovascular System. Ceiling mounted,

the imaging system provides unrestricted access to patient and full-

body x-ray coverage. Images displayed immediately on a multi-monitor

system for the physician
'/>"/>

SOURCE Heart Hospital of Austin
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death
2. Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk
3. Effect of tumor necrosis factor a inhibitors on heart failure risk in RA Patients
4. Specialized Care Essential for Women With Congenital Heart Disease Undergoing Pregnancy
5. New research indicates that a common heart drug
6. Statement of Robert Jarvik, MD, President and CEO of Jarvik Heart, Inc. Regarding the Lipitor DTC Advertisements
7. Adult Stem Cells Help Those With Immune Disorders, Heart Disease
8. Tips for Troublesome Medications, From the Harvard Heart Letter
9. VIDEO from Medialink and Siemens: NFL Stars Stress the Importance of a Healthy Heart
10. Heart attack rates fall following national smoking bans
11. Hidden Epidemic of Congestive Heart Failure Driving Hospitalization, Costs
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 1National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 2National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 3Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 1Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 2Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 3Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 4Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 5Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 6Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 7Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 8Improving Quality Cost Effectiveness and Time Savings in Preclinical Inhalable Formulation Development 6386 1Improving Quality Cost Effectiveness and Time Savings in Preclinical Inhalable Formulation Development 6386 2